First Time Loading...

Agilent Technologies Inc
NYSE:A

Watchlist Manager
Agilent Technologies Inc Logo
Agilent Technologies Inc
NYSE:A
Watchlist
Price: 137.74 USD 1% Market Closed
Updated: Apr 27, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

10.9B
+2%
Assets
Growth Rates:
1 Year
+0%
3 Years
+13%
5 Years
+22%
7 Years
+39%
10 Years
+3%
4.8B
-3%
Liabilities
Growth Rates:
1 Year
-10%
3 Years
-2%
5 Years
+22%
7 Years
+33%
10 Years
-8%
6.2B
+6%
Equity
Growth Rates:
1 Year
+10%
3 Years
+29%
5 Years
+23%
7 Years
+44%
10 Years
+14%

Balance Sheet Decomposition
Agilent Technologies Inc

10.9B
Assets
4.8B
Liabilities
10.9B
Assets
4.8B
Liabilities
Current Assets 4.3B
Cash & Short-Term Investments 1.7B
Receivables 1.3B
Other Current Assets 1.3B
Non-Current Assets 6.6B
Long-Term Investments 170m
PP&E 1.5B
Intangibles 4.4B
Other Non-Current Assets 561m
Current Liabilities 1.6B
Accounts Payable 488m
Accrued Liabilities 607m
Other Current Liabilities 522m
Non-Current Liabilities 3.1B
Long-Term Debt 2.6B
Other Non-Current Liabilities 588m

Balance Sheet
Agilent Technologies Inc

Rotate your device to view
Balance Sheet
Currency: USD
Oct-2014 Oct-2015 Oct-2016 Oct-2017 Oct-2018 Oct-2019 Oct-2020 Oct-2021 Oct-2022 Oct-2023
Assets
Cash & Cash Equivalents
2 218
2 003
2 289
2 678
2 247
1 382
1 441
1 484
1 053
1 590
Cash Equivalents
2 218
2 003
2 289
2 678
2 247
1 382
1 441
1 484
1 053
1 590
Short-Term Investments
0
0
0
0
0
0
0
91
0
0
Total Receivables
626
606
631
724
776
930
1 038
1 172
1 405
1 391
Accounts Receivables
626
606
631
724
776
930
1 038
1 172
1 405
1 291
Other Receivables
0
0
0
0
0
0
0
0
0
100
Inventory
574
541
533
575
638
679
720
830
1 038
1 031
Other Current Assets
2 091
536
182
192
187
198
216
222
282
174
Total Current Assets
5 509
3 686
3 635
4 169
3 848
3 189
3 415
3 799
3 778
4 186
PP&E Net
631
604
639
757
822
850
1 020
1 123
1 250
1 424
PP&E Gross
631
604
639
757
822
850
1 020
1 123
1 250
1 424
Accumulated Depreciation
738
723
767
843
838
925
1 029
1 122
1 148
1 223
Intangible Assets
649
445
416
361
491
1 107
831
981
821
475
Goodwill
2 507
2 366
2 517
2 607
2 973
3 593
3 602
3 975
3 952
3 960
Note Receivable
0
0
0
0
0
0
0
0
0
3
Long-Term Investments
96
86
135
138
68
102
158
185
195
164
Other Long-Term Assets
1 423
292
452
394
339
611
601
642
536
551
Other Assets
2 507
2 366
2 517
2 607
2 973
3 593
3 602
3 975
3 952
3 960
Total Assets
10 815
N/A
7 479
-31%
7 794
+4%
8 426
+8%
8 541
+1%
9 452
+11%
9 627
+2%
10 705
+11%
10 532
-2%
10 763
+2%
Liabilities
Accounts Payable
302
279
257
305
340
354
354
446
580
418
Accrued Liabilities
503
434
411
451
502
768
652
821
784
607
Short-Term Debt
0
0
0
110
0
615
75
0
36
0
Current Portion of Long-Term Debt
0
0
0
100
0
1
0
0
0
0
Other Current Liabilities
887
263
277
297
329
342
386
441
461
578
Total Current Liabilities
1 692
976
945
1 263
1 171
2 080
1 467
1 708
1 861
1 603
Long-Term Debt
1 663
1 655
1 904
1 801
1 799
1 791
2 284
2 729
2 733
2 735
Deferred Income Tax
0
0
0
0
0
0
0
0
0
38
Minority Interest
3
3
3
4
4
0
0
0
0
0
Other Liabilities
2 156
678
699
527
1 000
833
1 003
879
633
542
Total Liabilities
5 514
N/A
3 312
-40%
3 551
+7%
3 595
+1%
3 974
+11%
4 704
+18%
4 754
+1%
5 316
+12%
5 227
-2%
4 918
-6%
Equity
Common Stock
6
6
6
3
3
3
3
3
3
3
Retained Earnings
6 469
5 581
6 089
126
336
18
81
348
324
782
Additional Paid In Capital
8 967
9 045
9 159
5 300
5 308
5 277
5 311
5 320
5 325
5 387
Unrealized Security Profit/Loss
17
0
0
0
0
0
0
0
0
0
Treasury Stock
9 807
10 074
10 508
0
0
0
0
0
0
0
Other Equity
351
391
503
346
408
514
522
282
347
327
Total Equity
5 301
N/A
4 167
-21%
4 243
+2%
4 831
+14%
4 567
-5%
4 748
+4%
4 873
+3%
5 389
+11%
5 305
-2%
5 845
+10%
Total Liabilities & Equity
10 815
N/A
7 479
-31%
7 794
+4%
8 426
+8%
8 541
+1%
9 452
+11%
9 627
+2%
10 705
+11%
10 532
-2%
10 763
+2%
Shares Outstanding
Common Shares Outstanding
335
332
324
322
318
309
306
302
295
292

See Also

Summary
A intrinsic value, competitors valuation, and company profile.
DCF Valuation
A stock valuation using Discount Cash Flow valuation method.
Relative Valuation
A stock valuation using valuation multiples.
Wall Street Estimates
A price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
A stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 131,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.